Organ Donor Shortage Threatens Lives as Transplant Rates Decline

A significant decline in deceased organ donors has led to a drop in kidney transplants, posing serious risks for patients awaiting life-saving surgeries. In 2025, the number of deceased donor kidneys fell by four percent compared to the previous year, resulting in a total decrease of 663 donations. This alarming trend is unprecedented in the twenty-first century, despite improvements in live kidney donations and hospital efficiency.

Historically, when total transplants decreased, it was due to simultaneous drops in both living and deceased donations, often seen during economic downturns or health crises like the COVID-19 pandemic. However, in 2025, the landscape shifted dramatically. While living kidney donations surged and hospitals became more adept at utilizing kidneys that were previously considered marginal, these advancements were eclipsed by the decline in deceased donors.

The root cause of this issue is not a shortage of registered donors, but rather systemic challenges within the organ transplant process. Increased federal oversight and investigations, alongside heightened media scrutiny, have led to fears surrounding the integrity of organ procurement. According to a report by the nonprofit **Kidney Transplant Collaborative**, families and potential donors are withdrawing from registries at alarming rates due to concerns sparked by high-profile cases of mishandled organ donations.

Dr. Andy Howard, Chair of the **Kidney Transplant Collaborative**, emphasized the urgency of the situation, stating, “This is a serious signal for the transplant community and patients will feel the consequences quickly.” He noted that with adequate support and guidance, living kidney donations could significantly enhance transplant rates.

One prominent case that drew significant attention involved **TJ Hoover**, who was declared a candidate for organ donation after circulatory death in **October 2021**. Reports indicate that despite visible signs of consciousness, including eye movement and distress, staff proceeded with organ removal until a physician intervened. Hoover’s case sparked intense scrutiny and resulted in a comprehensive investigation by the **Health Resources and Services Administration (HRSA)**, leading to congressional hearings that questioned the safety and ethics of the current organ procurement system.

The focus on such cases has inadvertently created a climate of fear among organ procurement organizations (OPOs). Many are now hesitant to pursue donors after circulatory death, fearing potential backlash from investigations or negative media coverage. This caution is detrimental, as it limits the pool of available donors, especially since organs deteriorate quickly after cessation of cardiac function.

The decline in deceased donors, which began in **June 2025**, poses an immediate crisis for the approximately **94,000** Americans currently on the national kidney waiting list. Kidneys remain the most in-demand organ, and this sudden drop in supply threatens the well-being of a vulnerable patient population.

Despite the challenges, there has been a notable improvement in how hospitals manage the kidneys they receive. The discard rate fell by seven percent in 2025, reflecting a more effective approach to utilizing kidneys from high-risk or marginal donors. However, the ongoing donor shortage remains a pressing concern, particularly as the aging population increases the demand for transplants.

To combat this crisis, the **Kidney Transplant Collaborative** advocates for a shift in focus from fixing the troubled deceased donor system to bolstering living donations. A proposed solution includes the establishment of a national network of “transplant facilitators.” These trained professionals would assist potential donors through the entire process, from initial screenings to post-operative care, thereby reducing the dropout rates caused by fear of complications.

Evidence from programs at **Johns Hopkins University** and the **University of Alabama** demonstrates that such support can significantly enhance the likelihood of potential donors completing the screening process and ultimately becoming approved donors. The collaborative is calling for policy changes within **Medicare** to allow reimbursement for facilitator expenses, similar to the funding provided for deceased organ recovery.

Dr. Howard emphasized the need for action, stating, “We know people want to be living donors. They’re willing to do it, but we have to find a way to help them, and we feel the federal government needs to take action.”

As the organ donor shortage continues to escalate, the health of thousands of patients hangs in the balance. Immediate efforts to reform the organ procurement system and support living donations are crucial to ensure that those in need of transplants receive the care they deserve.